{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:25:59Z","timestamp":1792117559755,"version":"4.4.0"},"posted":{"date-parts":[[2025,4,16]]},"group-title":"Neuroscience","reference-count":94,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"award":["FS-2023-ESC-S2"],"award-info":[{"award-number":["FS-2023-ESC-S2"]}],"id":[{"id":"https:\/\/ror.org\/03fsqvg68","id-type":"ROR","asserted-by":"publisher"}]},{"award":["R01NS127186"],"award-info":[{"award-number":["R01NS127186"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"name":"MND Scotland\/ Chief Scientist Office","award":["CAF\/24\/13 \u2013 2024\/MNDS\/6500\/780ROB"],"award-info":[{"award-number":["CAF\/24\/13 \u2013 2024\/MNDS\/6500\/780ROB"]}]},{"award":["Gregory\/APR24\/2374-791"],"award-info":[{"award-number":["Gregory\/APR24\/2374-791"]}],"id":[{"id":"https:\/\/ror.org\/02gq0fg61","id-type":"ROR","asserted-by":"publisher"}]},{"award":["A20170"],"award-info":[{"award-number":["A20170"]}],"id":[{"id":"https:\/\/ror.org\/01dqb0q37","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023968","name":"NHS Grampian","doi-asserted-by":"crossref","award":["GCA25107"],"award-info":[{"award-number":["GCA25107"]}],"id":[{"id":"10.13039\/501100023968","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,10,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>The recognition that disease-associated proteinopathies can manifest in peripheral organs outside the central nervous system preceding the onset of neurological symptoms, has transformed our understanding of Parkinson\u2019s disease, in wide terms of pathogenesis, detection and diagnosis. For amyotrophic lateral sclerosis, non-motor symptoms, and non-central nervous system pathologies are gaining increased recognition but remain incompletely understood.<\/jats:p>\n                <jats:p>\n                  Here, using a TDP-43 RNA aptamer and a\n                  <jats:italic>Stathmin-2<\/jats:italic>\n                  cryptic exon transcript BaseScope\n                  <jats:sup>TM<\/jats:sup>\n                  ISH probe, we identify widespread peripheral organ TDP-43 pathology prior to motor symptom onset in a discovery cohort of ante-mortem tissues from people who went on to develop ALS. Peripheral organs exhibiting both TDP-43 toxic gain- and loss-of function include muscle, lymph node, gallbladder, colon and with notably high incidence, skin. Given the accessibility of skin as a readily biopsiable tissue, representing a promising substrate for the detection of disease-associated proteinopathies and the development of minimally invasive biomarkers, we established an extended cohort of ante-mortem skin samples for TDP-43 pathology validation and further investigation. In skin biopsies taken during life from 17 individuals who went on to develop ALS we identify TDP-43 pathology from all 17 individuals in a wide distribution of anatomical sites, up to 26.5 years before ALS diagnosis \u2013 a presymptomatic period comparable to that observed for skin \u03b1-synucleinopathy in Parkinson\u2019s disease. TDP-43 pathology was most abundant in skin biopsies from the back and shoulder, with sweat and sebaceous glands showing the highest involvement. TDP-43 pathology was also associated with structural changes.\n                <\/jats:p>\n                <jats:p>As skin \u03b1-synucleinopathy has been established as a biomarker for both the detection of Parkinson\u2019s disease and the differentiation of Parkinson\u2019s disease from multiple system atrophy, we propose that skin TDP-43 likewise holds diagnostic and discrimination potential for diseases characterised by TDP-43 proteinopathy.<\/jats:p>\n                <jats:sec>\n                  <jats:title>Short Abstract<\/jats:title>\n                  <jats:p>\n                    Peripheral manifestations of neurodegenerative disease can precede neurological symptoms and serve as biomarkers, as shown by \u03b1-synuclein in the skin of individuals who later develop Parkinson\u2019s disease. In amyotrophic lateral sclerosis (ALS), however, the distribution and diagnostic potential of peripheral TDP-43 pathology remain unclear. Using a TDP-43 RNA aptamer and a cryptic\n                    <jats:italic>STMN2<\/jats:italic>\n                    BaseScope\u2122 probe, we examined ante-mortem tissues from individuals who later developed ALS. In a discovery cohort, we detected widespread pre-symptomatic TDP-43 pathology across multiple organs, with skin emerging as the most consistent site. We then validated these findings in a validation cohort comprising 17 individuals, all of whom exhibited TDP-43 pathology enriched in sweat glands and structural changes detectable up to 26.5 years before ALS diagnosis. These findings establish skin as a robust and accessible site of pre-symptomatic TDP-43 pathology, supporting its potential as a minimally invasive biomarker for early diagnosis and disease stratification in ALS.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Summary<\/jats:title>\n                  <jats:p>Much like skin \u03b1-synucleinopathy has transformed biomarker development in Parkinson\u2019s disease, this study identifies skin TDP-43 pathology as a promising early marker of ALS. The results open avenues for earlier diagnosis and stratification in a disease where intervention is most needed before symptoms appear.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Graphical Abstract<\/jats:title>\n                  <jats:fig id=\"ufig1\" position=\"float\" orientation=\"portrait\" fig-type=\"figure\">\n                    <jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"648122v2_ufig1\" position=\"float\" orientation=\"portrait\"\/>\n                  <\/jats:fig>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Highlights<\/jats:title>\n                  <jats:list list-type=\"bullet\">\n                    <jats:list-item>\n                      <jats:p>Presymptomatic TDP-43 pathology occurs across a range on non-CNS peripheral organ systems including skin, gastrointestinal tract and lymph nodes prior to motor symptom onset in people who went on to develop ALS.<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>In skin, presymptomatic TDP-43 pathology is associated with structural changes and can be detected up to 26.5 years prior to motor symptoms in ALS.<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>As for Parkinson\u2019s disease, shoulder and back represents optimal skin sampling sites for pre-symptomatic pathology in ALS.<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>Sweat and sebaceous glands present with high levels of TDP-43 pathology, offering a promising biomarker target for early pathology detection.<\/jats:p>\n                    <\/jats:list-item>\n                  <\/jats:list>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>One Sentence Summary<\/jats:title>\n                  <jats:p>Using distinct biomarker discovery and validation ante-mortem tissue cohorts, we provide evidence of pre-symptomatic TDP-43 pathology across diverse non-CNS peripheral tissues, including skin decades before ALS symptom onset, highlighting skin TDP-43 pathology as a potential early biomarker for ALS and related TDP-43 proteinopathies<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2025.04.10.648122","type":"posted-content","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T11:53:01Z","timestamp":1745409181000},"source":"Crossref","is-referenced-by-count":10,"title":["Skin TDP-43 pathology as a candidate biomarker for predicting amyotrophic lateral sclerosis decades prior to motor symptom onset"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2622-0776","authenticated-orcid":false,"given":"Fergal M.","family":"Waldron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4000-5703","authenticated-orcid":false,"given":"Tatiana","family":"Langerov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aydan","family":"Rahmanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2327-3514","authenticated-orcid":false,"given":"Fiona L.","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1628-6790","authenticated-orcid":false,"given":"Holly","family":"Spence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5596-9642","authenticated-orcid":false,"given":"Kristine","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6284-4239","authenticated-orcid":false,"given":"Angus D.","family":"Macleod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0482-1909","authenticated-orcid":false,"given":"Samuel B.","family":"Pattle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8348-2399","authenticated-orcid":false,"given":"Katie","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3337-4079","authenticated-orcid":false,"given":"Jenna M.","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2025100713450618000_2025.04.10.648122v2.1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41531-022-00436-2","article-title":"A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson\u2019s disease","volume":"8","year":"2022","journal-title":"npj Parkinson\u2019s Disease"},{"key":"2025100713450618000_2025.04.10.648122v2.2","doi-asserted-by":"crossref","first-page":"S281","DOI":"10.3233\/JPD-191721","article-title":"Brain-First versus Gut-First Parkinson\u2019s Disease: A Hypothesis","volume":"9","year":"2019","journal-title":"Journal of Parkinson\u2019s Disease"},{"key":"2025100713450618000_2025.04.10.648122v2.3","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-013-1214-6"},{"key":"2025100713450618000_2025.04.10.648122v2.4","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25020"},{"key":"2025100713450618000_2025.04.10.648122v2.5","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24648"},{"key":"2025100713450618000_2025.04.10.648122v2.6","doi-asserted-by":"crossref","unstructured":"Y. Yang , Z. Zhang , \u03b1-Synuclein pathology from the body to the brain: so many seeds so close to the central soil. Neural Regeneration Research 19, (2024).","DOI":"10.4103\/1673-5374.387967"},{"key":"2025100713450618000_2025.04.10.648122v2.7","doi-asserted-by":"crossref","unstructured":"H. Peng et al., Alpha-synuclein in skin as a high-quality biomarker for Parkinson\u2019s disease. Journal of the Neurological Sciences 451, 120730 (2023).","DOI":"10.1016\/j.jns.2023.120730"},{"key":"2025100713450618000_2025.04.10.648122v2.8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011935"},{"key":"2025100713450618000_2025.04.10.648122v2.9","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3233\/JPD-202489","article-title":"Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson\u2019s Disease","volume":"11","year":"2021","journal-title":"Journal of Parkinson\u2019s Disease"},{"key":"2025100713450618000_2025.04.10.648122v2.10","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/brain\/awac124","article-title":"Phosphorylated \u03b1-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy","volume":"146","year":"2023","journal-title":"Brain"},{"key":"2025100713450618000_2025.04.10.648122v2.11","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000206772"},{"key":"2025100713450618000_2025.04.10.648122v2.12","doi-asserted-by":"crossref","unstructured":"W. P. Huang et al., Stress-induced TDP-43 nuclear condensation causes splicing loss of function and STMN2 depletion. Cell reports 43, 114421 (2024).","DOI":"10.1016\/j.celrep.2024.114421"},{"key":"2025100713450618000_2025.04.10.648122v2.13","doi-asserted-by":"publisher","DOI":"10.1126\/science.1134108"},{"key":"2025100713450618000_2025.04.10.648122v2.14","doi-asserted-by":"crossref","unstructured":"H. Spence et al., RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with STMN-2 cryptic splicing and precedes clinical manifestation in ALS. Acta neuropathologica 147, 50 (2024).","DOI":"10.1007\/s00401-024-02705-1"},{"key":"2025100713450618000_2025.04.10.648122v2.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10651-1"},{"key":"2025100713450618000_2025.04.10.648122v2.16","doi-asserted-by":"publisher","DOI":"10.1016\/bs.irn.2017.04.009"},{"key":"2025100713450618000_2025.04.10.648122v2.17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3233\/JND-210632","article-title":"Non-Motor Symptoms of Amyotrophic Lateral Sclerosis: A Multi-Faceted Disorder","volume":"8","year":"2021","journal-title":"Journal of neuromuscular diseases"},{"key":"2025100713450618000_2025.04.10.648122v2.18","doi-asserted-by":"crossref","unstructured":"A. Shojaie , S. Rota , A. Al Khleifat , K. Ray Chaudhuri , A. Al-Chalabi , Non-motor symptoms in amyotrophic lateral sclerosis: lessons from Parkinson\u2019s disease. Amyotrophic lateral sclerosis & frontotemporal degeneration, 1\u201310 (2023).","DOI":"10.1080\/21678421.2023.2263868"},{"key":"2025100713450618000_2025.04.10.648122v2.19","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2023-331697"},{"key":"2025100713450618000_2025.04.10.648122v2.20","doi-asserted-by":"crossref","unstructured":"E. Beswick et al., Non-motor symptoms in motor neuron disease: prevalence, assessment and impact. Brain communications 6, fcad336 (2023).","DOI":"10.1093\/braincomms\/fcad336"},{"key":"2025100713450618000_2025.04.10.648122v2.21","unstructured":"E. Conroy et al., IMPACT-ALS: summary of results from a European survey of people living with ALS. Amyotrophic lateral sclerosis & frontotemporal degeneration, 1\u201310 (2023)."},{"key":"2025100713450618000_2025.04.10.648122v2.22","doi-asserted-by":"crossref","unstructured":"R. G\u00fcnther et al., Non-Motor Symptoms in Patients Suffering from Motor Neuron Diseases. Frontiers in neurology 7, 117 (2016).","DOI":"10.3389\/fneur.2016.00117"},{"key":"2025100713450618000_2025.04.10.648122v2.23","doi-asserted-by":"crossref","first-page":"172","DOI":"10.12968\/bjnn.2023.19.5.172","article-title":"BowALS: understanding changing bowel habits in people with amyotrophic lateral sclerosis","volume":"19","year":"2023","journal-title":"British Journal of Neuroscience Nursing"},{"key":"2025100713450618000_2025.04.10.648122v2.24","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.2127"},{"key":"2025100713450618000_2025.04.10.648122v2.25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/21678421.2020.1828475","article-title":"The human gut microbiota in people with amyotrophic lateral sclerosis","volume":"22","year":"2021","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2025100713450618000_2025.04.10.648122v2.26","doi-asserted-by":"crossref","unstructured":"T. Niu et al., An overlap-weighted analysis on the association of constipation symptoms with disease progression and survival in amyotrophic lateral sclerosis: a nested case-control study. Therapeutic advances in neurological disorders 18, 17562864241309811 (2025).","DOI":"10.1177\/17562864241309811"},{"key":"2025100713450618000_2025.04.10.648122v2.27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/21678421.2013.868001","article-title":"Increased prevalence of bladder and intestinal dysfunction in amyotrophic lateral sclerosis","volume":"15","year":"2014","journal-title":"Amyotrophic lateral sclerosis & frontotemporal degeneration"},{"key":"2025100713450618000_2025.04.10.648122v2.28","doi-asserted-by":"publisher","DOI":"10.1002\/cjp2.297"},{"key":"2025100713450618000_2025.04.10.648122v2.29","doi-asserted-by":"crossref","unstructured":"V. C. Samara , P. Jerant , S. Gibson , M. Bromberg , Bowel, bladder, and sudomotor symptoms in ALS patients. Journal of the neurological sciences 427, 117543 (2021).","DOI":"10.1016\/j.jns.2021.117543"},{"key":"2025100713450618000_2025.04.10.648122v2.30","first-page":"62","article-title":"The \u201cinstitutional colon\u201d: a frequent colonic dysmotility in psychiatric and neurologic disease","volume":"89","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"2025100713450618000_2025.04.10.648122v2.31","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2021.1883666"},{"key":"2025100713450618000_2025.04.10.648122v2.32","unstructured":"T. A. Association , \u201cThe Voice of the Patient for Amyotrophic Lateral Sclerosis (ALS),\u201d (2019)."},{"key":"2025100713450618000_2025.04.10.648122v2.33","first-page":"15","article-title":"Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology","volume":"1","year":"1999","journal-title":"Research Group on Motor Neuron Diseases"},{"key":"2025100713450618000_2025.04.10.648122v2.34","doi-asserted-by":"publisher","DOI":"10.1159\/000007708"},{"key":"2025100713450618000_2025.04.10.648122v2.35","first-page":"473","article-title":"Delayed colonic transit times in amyotrophic lateral sclerosis assessed with radio-opaque markers","volume":"2","year":"1997","journal-title":"European journal of medical research"},{"key":"2025100713450618000_2025.04.10.648122v2.36","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12936"},{"key":"2025100713450618000_2025.04.10.648122v2.37","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-325164"},{"key":"2025100713450618000_2025.04.10.648122v2.38","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000286948.99150.16"},{"key":"2025100713450618000_2025.04.10.648122v2.39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/17482960701538825","article-title":"Pressure ulcers in ALS patients on admission at a university hospital in Japan","volume":"8","year":"2007","journal-title":"Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases"},{"key":"2025100713450618000_2025.04.10.648122v2.40","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0140-6736(96)90737-0","article-title":"Skin involvement in amyotrophic lateral sclerosis","volume":"347","year":"1996","journal-title":"The Lancet"},{"key":"2025100713450618000_2025.04.10.648122v2.41","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad426"},{"key":"2025100713450618000_2025.04.10.648122v2.42","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12332"},{"key":"2025100713450618000_2025.04.10.648122v2.43","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.1.114"},{"key":"2025100713450618000_2025.04.10.648122v2.44","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.36.7.948"},{"key":"2025100713450618000_2025.04.10.648122v2.45","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1515\/revneuro-2017-0004","article-title":"Potential skin involvement in ALS: revisiting Charcot\u2019s observation - a review of skin abnormalities in ALS","volume":"28","year":"2017","journal-title":"Reviews in the neurosciences"},{"key":"2025100713450618000_2025.04.10.648122v2.46","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2006.098533"},{"key":"2025100713450618000_2025.04.10.648122v2.47","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-015-7672-0"},{"key":"2025100713450618000_2025.04.10.648122v2.48","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3109\/21678421.2014.951944","article-title":"The evaluation of pain in amyotrophic lateral sclerosis: a case controlled observational study","volume":"15","year":"2014","journal-title":"Amyotrophic lateral sclerosis & frontotemporal degeneration"},{"key":"2025100713450618000_2025.04.10.648122v2.49","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821e553a"},{"key":"2025100713450618000_2025.04.10.648122v2.50","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-025-01914-5"},{"key":"2025100713450618000_2025.04.10.648122v2.51","doi-asserted-by":"crossref","unstructured":"M. D. Cykowski et al., Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis. Acta neuropathologica communications 6, 28 (2018).","DOI":"10.1186\/s40478-018-0528-y"},{"key":"2025100713450618000_2025.04.10.648122v2.52","doi-asserted-by":"crossref","unstructured":"F. Mori et al., Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions. Acta neuropathologica communications 7, 165 (2019).","DOI":"10.1186\/s40478-019-0824-1"},{"key":"2025100713450618000_2025.04.10.648122v2.53","first-page":"e13261","article-title":"Detection of pTDP-43 via routine muscle biopsy: A promising diagnostic biomarker for amyotrophic lateral sclerosis. Brain pathology (Zurich","volume":"34","year":"2024","journal-title":"Switzerland"},{"key":"2025100713450618000_2025.04.10.648122v2.54","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamaneurol.2022.1113","article-title":"TDP-43 Accumulation Within Intramuscular Nerve Bundles of Patients With Amyotrophic Lateral Sclerosis","volume":"79","year":"2022","journal-title":"JAMA neurology"},{"key":"2025100713450618000_2025.04.10.648122v2.55","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02788-5"},{"key":"2025100713450618000_2025.04.10.648122v2.56","doi-asserted-by":"crossref","unstructured":"J. M. Gregory et al., Executive, language and fluency dysfunction are markers of localised TDP-43 cerebral pathology in non-demented ALS. Journal of Neurology, Neurosurgery && Psychiatry 91, 149 (2020).","DOI":"10.1136\/jnnp-2019-320807"},{"key":"2025100713450618000_2025.04.10.648122v2.57","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1038\/s41467-022-30944-x","article-title":"Probing TDP-43 condensation using an in silico designed aptamer","volume":"13","year":"2022","journal-title":"Nature Communications"},{"key":"2025100713450618000_2025.04.10.648122v2.58","doi-asserted-by":"crossref","unstructured":"F. M. Waldron , H. Spence , J. M. Gregory , TDP-43 RNA aptamer staining to detect pathological TDP-43 in FFPE human tissue, as described in Spence and Waldron, et al., 2024 (Acta Neuropathologica): A SOP and tick-sheet. protocols.io, (2024).","DOI":"10.17504\/protocols.io.eq2lyjo4mlx9\/v2"},{"key":"2025100713450618000_2025.04.10.648122v2.59","doi-asserted-by":"crossref","unstructured":"H. Spence et al., RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with STMN-2 cryptic splicing and precedes clinical manifestation in ALS. Acta Neuropathologica 147, 50 (2024).","DOI":"10.1007\/s00401-024-02705-1"},{"key":"2025100713450618000_2025.04.10.648122v2.60","doi-asserted-by":"crossref","first-page":"fcad336","DOI":"10.1093\/braincomms\/fcad336","article-title":"Non-motor symptoms in motor neuron disease: prevalence, assessment and impact","volume":"6","year":"2023","journal-title":"Brain Communications"},{"key":"2025100713450618000_2025.04.10.648122v2.61","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3233\/JND-210632","article-title":"Non-Motor Symptoms of Amyotrophic Lateral Sclerosis: A Multi-Faceted Disorder","volume":"8","year":"2021","journal-title":"Journal of Neuromuscular Diseases"},{"key":"2025100713450618000_2025.04.10.648122v2.62","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1080\/21678421.2023.2220748","article-title":"Non-motor symptoms in amyotrophic lateral sclerosis: lessons from Parkinson\u2019s disease","volume":"24","year":"2023","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"key":"2025100713450618000_2025.04.10.648122v2.63","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac185"},{"key":"2025100713450618000_2025.04.10.648122v2.64","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab404"},{"key":"2025100713450618000_2025.04.10.648122v2.65","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S1474-4422(22)00120-X","article-title":"A biological classification of Huntington\u2019s disease: the Integrated Staging System","volume":"21","year":"2022","journal-title":"The Lancet Neurology"},{"key":"2025100713450618000_2025.04.10.648122v2.66","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"20","year":"2024","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"2025100713450618000_2025.04.10.648122v2.67","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","article-title":"A biological definition of neuronal alpha-synuclein disease: towards an integrated staging system for research","volume":"23","year":"2024","journal-title":"The Lancet Neurology"},{"key":"2025100713450618000_2025.04.10.648122v2.68","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41582-024-00961-z","article-title":"The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology","volume":"20","year":"2024","journal-title":"Nature Reviews Neurology"},{"key":"2025100713450618000_2025.04.10.648122v2.69","doi-asserted-by":"crossref","first-page":"fcab242","DOI":"10.1093\/braincomms\/fcab242","article-title":"Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective","volume":"3","year":"2021","journal-title":"Brain communications"},{"key":"2025100713450618000_2025.04.10.648122v2.70","doi-asserted-by":"crossref","unstructured":"E. Zacco et al., Computationally Designed RNA Aptamers Enable Selective Detection of FUS Pathology in ALS. bioRxiv, 2025.2004.2030.651570 (2025).","DOI":"10.1101\/2025.04.30.651570"},{"key":"2025100713450618000_2025.04.10.648122v2.71","doi-asserted-by":"crossref","unstructured":"K. Chang et al., Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer\u2019s disease neuropathologic changes and cognitive decline. Acta Neuropathologica 147, 4 (2023).","DOI":"10.1007\/s00401-023-02653-2"},{"key":"2025100713450618000_2025.04.10.648122v2.72","doi-asserted-by":"crossref","unstructured":"L. Versluys et al., Expanding the TDP-43 Proteinopathy Pathway From Neurons to Muscle: Physiological and Pathophysiological Functions. Frontiers in neuroscience 16, 815765 (2022).","DOI":"10.3389\/fnins.2022.815765"},{"key":"2025100713450618000_2025.04.10.648122v2.73","doi-asserted-by":"publisher","DOI":"10.1172\/JCI130988"},{"key":"2025100713450618000_2025.04.10.648122v2.74","first-page":"159","article-title":"Frontotemporal dementia-associated protein \u201cphosphorylated TDP-43\u201d localizes to atherosclerotic lesions of human carotid and main cerebral arteries","volume":"35","year":"2020","journal-title":"Histol Histopathol"},{"key":"2025100713450618000_2025.04.10.648122v2.75","doi-asserted-by":"crossref","unstructured":"Y. Katsumata , D. W. Fardo , W. A. Kukull , P. T. Nelson , Dichotomous scoring of TDP-43 proteinopathy from specific brain regions in 27 academic research centers: associations with Alzheimer\u2019s disease and cerebrovascular disease pathologies. Acta neuropathologica communications 6, 142 (2018).","DOI":"10.1186\/s40478-018-0641-y"},{"key":"2025100713450618000_2025.04.10.648122v2.76","doi-asserted-by":"crossref","unstructured":"V. Arribas , et al., Endothelial TDP-43 controls sprouting angiogenesis and vascular barrier integrity, and its deletion triggers neuroinflammation. JCI insight 9, (2024).","DOI":"10.1172\/jci.insight.177819"},{"key":"2025100713450618000_2025.04.10.648122v2.77","doi-asserted-by":"crossref","unstructured":"A. Cheemala , et al., Loss of Endothelial TDP-43 Leads to Blood Brain Barrier Defects in Mouse Models of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. bioRxiv : the preprint server for biology, (2023).","DOI":"10.1101\/2023.12.13.571184"},{"key":"2025100713450618000_2025.04.10.648122v2.78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2024.03.003"},{"key":"2025100713450618000_2025.04.10.648122v2.79","doi-asserted-by":"crossref","unstructured":"D. Shan et al., FUS protein nuclear loss in skin biopsy: A window into the pathology and diagnosis of fused in sarcoma-associated amyotrophic lateral sclerosis. Journal of Neuropathology & Experimental Neurology, nlaf077 (2025).","DOI":"10.1093\/jnen\/nlaf077"},{"key":"2025100713450618000_2025.04.10.648122v2.80","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-4580(02)00065-9"},{"key":"2025100713450618000_2025.04.10.648122v2.81","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2007.00874.x"},{"key":"2025100713450618000_2025.04.10.648122v2.82","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-025-01910-9"},{"key":"2025100713450618000_2025.04.10.648122v2.83","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41531-024-00738-7","article-title":"A skin-specific \u03b1-Synuclein seeding amplification assay for diagnosing Parkinson\u2019s disease","volume":"10","year":"2024","journal-title":"npj Parkinson\u2019s Disease"},{"key":"2025100713450618000_2025.04.10.648122v2.84","doi-asserted-by":"crossref","unstructured":"S. Briganti et al., Application of Sebum Lipidomics to Biomarkers Discovery in Neurodegenerative Diseases. Metabolites 11, (2021).","DOI":"10.3390\/metabo11120819"},{"key":"2025100713450618000_2025.04.10.648122v2.85","doi-asserted-by":"publisher","DOI":"10.1023\/A:1003528507828"},{"key":"2025100713450618000_2025.04.10.648122v2.86","doi-asserted-by":"publisher","DOI":"10.1016\/J.JMOLDX.2011.08.002"},{"key":"2025100713450618000_2025.04.10.648122v2.87","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12575"},{"key":"2025100713450618000_2025.04.10.648122v2.88","doi-asserted-by":"crossref","unstructured":"P. Bankhead et al., QuPath: Open source software for digital pathology image analysis. Scientific Reports 7, 16878 (2017).","DOI":"10.1038\/s41598-017-17204-5"},{"key":"2025100713450618000_2025.04.10.648122v2.89","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/path.6008","article-title":"Random forest modelling demonstrates microglial and protein misfolding features to be key phenotypic markers in C9orf72-ALS","volume":"258","year":"2022","journal-title":"The Journal of Pathology"},{"key":"2025100713450618000_2025.04.10.648122v2.90","doi-asserted-by":"crossref","unstructured":"O. M. Rifai et al., Amygdala TDP-43 pathology is associated with behavioural dysfunction and ferritin accumulation in amyotrophic lateral sclerosis. bioRxiv, 2024.2006.2001.596819 (2024).","DOI":"10.1101\/2024.06.01.596819"},{"key":"2025100713450618000_2025.04.10.648122v2.91","unstructured":"R. C. Team, R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. <https:\/\/www.R-project.org\/>. (2025)."},{"key":"2025100713450618000_2025.04.10.648122v2.92","unstructured":"John Fox , S. Weisberg , An R Companion to Applied Regression, Third Edition. Sage, Thousand Oaks CA. URL: https:\/\/socialsciences.mcmaster.ca\/jfox\/Books\/Companion\/. (2019)."},{"key":"2025100713450618000_2025.04.10.648122v2.93","doi-asserted-by":"publisher","DOI":"10.21105\/joss.01686"},{"key":"2025100713450618000_2025.04.10.648122v2.94","unstructured":"W. H, ggplot 2: Elegant Graphics for Data Analysis. Springer-Verlag New York., (2016)."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.04.10.648122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T08:29:49Z","timestamp":1768465789000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.04.10.648122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":94,"URL":"https:\/\/doi.org\/10.1101\/2025.04.10.648122","relation":{},"subject":[],"published":{"date-parts":[[2025,4,16]]},"subtype":"preprint"}}